Yokohama, Japan

Who wants to get the inside scoop on emerging CAR-T cell therapies for solid tumours such as lung cancer?

In our latest post you can learn how scientists in China are engineering innovative multi-functional CAR-T cells to overcome challenges.

These include tumour heterogeneity and an immunosuppressive tumour microenvironment.

This cutting edge research could promise to open new frontiers in solid tumour treatment and offer some directions for further advances.

Don’t miss this sneak peek on early clinical trial data…

To continue reading our latest highlights on oncology new product development including commentary and analysis, BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by